Prevention of osteoporosis is still a valid aim for hormone therapy

By Sturdee David   MacLennan Alastair  

Climacteric, Vol. 8, Iss. 2, 2005-06 ,pp. : 97-98

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and prevention of osteoporosis: risk assessment and practical advice

By Balogh A.   Bettembuk P.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 2, 1997-02 ,pp. : 189-191

Elsevier

Access to resources Recommend Favorite

Hormone replacement therapy: compliance and cost after screening for osteoporosis

By Torgerson D.J.   Donaldson C.   Russell I.T.   Reid D.M.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 1, 1995-03 ,pp. : 57-60

Elsevier

Access to resources Recommend Favorite

Osteoporosis risk factors: association with use of hormone replacement therapy and with worry about osteoporosis - the Framingham study

By Osborn B.H.   Couchman G.M.   Siegler I.C.   Bastian L.A.  

Women's Health Issues, Vol. 9, Iss. 6, 1999-11 ,pp. : 278-285

Elsevier

Access to resources Recommend Favorite

Vaginal dilator therapy-an outpatient gynaecological option in the management of dyspareunia

By Idama T. O.   Pring D. W.  

Journal of Obstetrics & Gynaecology, Vol. 20, Iss. 3, 2000-05 ,pp. : 303-305

Informa Healthcare

Access to resources Recommend Favorite